OptiNose Surges on FDA Expansion for XHANCE and Strong Revenue Growth
OptiNose (NASDAQ:OPTN) is making significant gains in Thursday’s trading session after the company unveiled positive updates regarding its flagship product, XHANCE, and reported robust revenue